8-K filing — Genprex, Inc. (GNPX)
Filed: 2026-08-18 AccNo: 0001437749-26-028250 Size: 171 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Genprex Announces Development And Manufacturing Agreement With Undisclosed U.S. CDMO To Scale Up cGMP Production Of Diabetes Gene Therapy For IND-Enabling Studies, Future Trials
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers INVO Fertility (NASDAQ:IVF) stock moved upwards by 13.1% to $1.73 during Monday's after-market session. The company's market cap stands at $1.7 million. The company's, Q2 earnings came out today.
Genprex shares are trading lower. The company announced its collaboration with Roche Diagnostics to validate biomarkers for patient selection in clinical trials for non-small cell lung cancer.